NASDAQ:ATOS   Atossa Therapeutics, Inc.
who doesnt like generic epi pens …. current level and under seem legit enough for the risk.
Comment:
half way there...
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.